The Mix Tape

The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval

37 min · 27. sept. 2023
episode The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval cover

Description

In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences, advice on how best to prepare for commercialization, and leading commercial teams. This 2-part special edition, is brought to you by Mix Talent [https://www.linkedin.com/company/mix-talent/] and ADVI Health [https://www.linkedin.com/company/advi/] to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization.

Comments

0

Be the first to comment

Sign up now and become a member of the The Mix Tape community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

37 episodes

episode The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval artwork

The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval

In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences, advice on how best to prepare for commercialization, and leading commercial teams. This 2-part special edition, is brought to you by Mix Talent [https://www.linkedin.com/company/mix-talent/] and ADVI Health [https://www.linkedin.com/company/advi/] to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization.

27. sept. 202337 min
episode The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Development and Manufacturing artwork

The Mix Tape | Special Edition - Cell and Gene Tx Journey to Commercialization: Drug Development and Manufacturing

Welcome back to The Mix Tape! In this 2-part special edition, Mix Talent [https://www.linkedin.com/company/mix-talent/] teamed up with ADVI Health [https://www.linkedin.com/company/advi/] to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization. This series will feature insights from our incredible guests on their learnings from past experiences, tips and tricks, and anticipated trends in biotech. In this episode, Mix Talent's Director of Client Solutions and Scientific Partnerships, Tori Schaefer, is joined by Susan Nichols (President and CEO of Propel Biosciences) and Adora Ndu (Chief Regulatory Officer at BridgeBio) to discuss drug development and manufacturing for cell and gene therapies. Susan and Adora will discuss learnings from past experiences, how to become part of the solution for the future success of cell and gene therapy, the value of the patient community, and their prediction that things are looking up for gene and cell therapy from all corners of the business.

20. sept. 202333 min